Authors
-
Anastasia Shumeikina
Institute of Oncology and Neurosurgery of the Federal State Budgetary Institution National Medical Research Center named ak. E.N. Meshalkin, 630055, Novosibirsk, Russia.
Author
-
Sergey Krasilnikov
Federal State Budget Scientific Institution “Federal Research Center of Fundamental and Translational Medicine”, 630060, Novosibirsk, Russia
Author
-
Maria Kostromina
Moscow State University named after M.V. Lomonosov, Faculty of Fundamental Medicine; 119991, Moscow, Russia
Author
-
Elizaveta Zhdanova
Novosibirsk State University, 630090, Novosibirsk, Russia
Author
-
Alexander Tarkhov
State Budgetary Healthcare Institution City Clinical Hospital No. 1, 630047, Novosibirsk, Russia
Author
-
Alexander Ponomarenko
Novosibirsk Regional Clinical Oncology Dispensary, 630108, Novosibirsk, Russia
Author
Keywords:
Supraclavicular, Lymph Nodes, Cervical Cancer
Abstract
Recurrence of cervical cancer occurs in 5-50% of cases depending on the stage of the disease, tumor histotype. Supraclavicular lymph nodes in cervical cancer are affected in 2% of cases, following in prevalence after para-aortic lymph nodes. Treatment strategies for these patients are limited to palliative therapy, but modern capabilities allow for effective and safe treatment. We present a clinical case - metastatic cervical cancer to the supraclavicular lymph nodes and lungs in stage I cervical cancer in a young patient.
Author Biography
-
Anastasia Shumeikina, Institute of Oncology and Neurosurgery of the Federal State Budgetary Institution National Medical Research Center named ak. E.N. Meshalkin, 630055, Novosibirsk, Russia.
Anastasia Shumeikina, Institute of Oncology and Neurosurgery of the Federal State Budgetary Institution National Medical Research Center named ak. E.N. Meshalkin, 630055, Novosibirsk, Russia.
